Following a hold-up and a remarkably divisive gathering, a national immunization advisory committee was set to cast ballots on Friday concerning altering the long-held guideline that all newborns be immunized against hepatitis B.
The initial day of the conference on Thursday was characterized by heated debate over restricting access to the hepatitis B vaccine for babies and a choice to delay the ballot by a day to give members more time to scrutinize the phrasing. The committee, which counsels the national health agency on vaccination protocols, had put off the vote twice in the past.
“Is there any specific evidence of damage of giving this immunization before 30 days? Or is this conjecture?” questioned one committee member.
In reply, another attendee stated, “There is inadequate data about the enduring danger.”
The injection is presently advised for every newborn within 24 hours of birth to halt contraction of hepatitis B, which can result in serious liver damage. It has been provided to over a billion individuals for more than three decades.
The Atlanta conference presented no recent proof of damage attributable to the vaccine. Experts say any modification to the current hepatitis B vaccination schedule could have profound and widespread repercussions for pediatric well-being in the United States.
The expert committee can only make recommendations to the director of the CDC. The group's roster has experienced alterations recently, with the statement that the group's former head would depart for an official role and be substituted with a cardiac doctor who has been questioning of other vaccines.
The board includes multiple vaccination critics who are in agreement with a aim to revamp – and potentially, in some cases, scrap – longstanding immunization guidelines.
Award-winning investigative journalist with over 15 years of experience covering political and social issues across Europe.
Alexandra James
Alexandra James
Alexandra James
Alexandra James
Alexandra James
Alexandra James